Table 1 Baseline demographic and clinical features in complete vs. partial PVD.
Variables | Complete PVD (n = 46) | Partial PVD (n = 124) | P valueb |
|---|---|---|---|
Demographic and clinical featuresa | |||
Mean age in years (SD) | 47.1 (8.4) | 36.5 (10.3) | < 0.001 |
20–29 y, n (%) | 2 (4.4) | 38 (30.7) | |
30–39 y, n (%) | 7 (15.2) | 39 (31.5) | |
40–49 y, n (%) | 19 (41.3) | 33 (26.6) | |
50–59 y, n (%) | 18 (39.1) | 14 (11.3) | |
Sex, n (%) | 0.40 | ||
Male | 23 (50.0) | 71 (57.3) | |
Spherical equivalent, diopter (SD) | − 11.4 (5.1) | − 8.68 (4.2) | < 0.001 |
Axial length, mm (SD) | 27.9 (1.3) | 27.4 (1.1) | 0.01 |
Central retinal thickness, μm (SD) | 217.4 (23.7) | 217.4 (20.0) | 0.99 |
Choroidal thickness, μm (SD) | 197.7 (75.6) | 223.2 (76.7) | 0.05 |
LogMAR CDVA, (SD) | − 0.25 (0.38) | − 0.04 (0.18) | < 0.001 |
PVD stage, n (%) | |||
Stage 1 | NA | 101 (81.5) | |
Stage 2 | NA | 13 (10.5) | |
Stage 3 | NA | 10 (8.1) | |
Stage 4 | 46 (100) | NA | |